Latest News & Updates | Lymphoma Canada Announcements

News Press Releases

Dynacare Selects Lymphoma Canada as 2015 Lead Charity

Lymphoma Canada will receive a $25,000 donation to be directed toward research to improve the…

adminSeptember 2, 2015

Research

New Obinutuzumab Study Published

Obinutuzumab (Gazyva) improved overall response and had acceptable toxicity compared with rituximab (Rituxan) in patients…

adminAugust 25, 2015

Research

Brentuximab Vedotin as Second-Line Therapy before Autologous Transplantation

Brentuximab Vedotin is Effective as Salvage Therapy in Patients with Relapsed/Refractory Hodgkin Lymphoma Prior to…

adminAugust 17, 2015

Research

BC Cancer Agency Researchers Develop Improved Prognostic Test for Follicular Lymphoma

Mutation patterns in seven genes may help predict outcomes for individuals with follicular lymphoma

adminAugust 10, 2015

News Research

Health Canada Approves ibrutinib for Mantle Cell Lymphoma

Health Canada has issued a Notice of Compliance with Conditions (NOC/c) for ibrutinib (Imbruvica®), a…

adminJuly 31, 2015

News

Matt’s Head-Shaving Fundraiser

The head-shaving event at their house raised $1,800 with over 35 people attending and 16…

adminJuly 30, 2015

News

Lymphoma Canada 2015 Research Fellowship Award

Lymphoma Canada is pleased to award its 2015 Research Fellowship to Dr. Kerry Savage, a…

adminJuly 30, 2015

Press Releases

take it to the mat Press Release July 2015

TORONTO, July 7, 2015—take it to the mat, The Great Yoga & Wellness Revolution, in…

adminJuly 23, 2015

News Research

Specific subtype of diffuse large B-cell lymphoma more likely to respond to ibrutinib

A recent study shows that patients with a specific molecular subtype of diffuse large B-cell…

adminJuly 21, 2015

News Research

Aggressive lymphoma linked to disruption in cell energy production

A new study finds evidence that a genetic enzyme deficiency that affects the ability of…

adminJuly 20, 2015

Mon	Tue	Wed	Thu	Fri	Sat	Sun
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

News & Media

Dynacare Selects Lymphoma Canada as 2015 Lead Charity

New Obinutuzumab Study Published

Brentuximab Vedotin as Second-Line Therapy before Autologous Transplantation

BC Cancer Agency Researchers Develop Improved Prognostic Test for Follicular Lymphoma

Health Canada Approves ibrutinib for Mantle Cell Lymphoma

Matt’s Head-Shaving Fundraiser

Lymphoma Canada 2015 Research Fellowship Award

take it to the mat Press Release July 2015

Specific subtype of diffuse large B-cell lymphoma more likely to respond to ibrutinib

Aggressive lymphoma linked to disruption in cell energy production

Are you a patient?

Are you a healthcare professional?

Upcoming Events

Contact Us

Donate

Careers

Join Our Mailing List